Form 424B8 - Prospectus filed pursuant to Rule 424(b)(8)
August 12 2024 - 4:07PM
Edgar (US Regulatory)
Amendment no. 1 to pricing supplement dated July 12, 2024
To prospectus dated April 13, 2023,
prospectus supplement dated April 13, 2023,
product supplement no. 3-I dated April 13, 2023,
underlying supplement no. 1-I dated April 13, 2023 and
prospectus addendum dated June 3, 2024 |
Registration Statement Nos. 333-270004 and 333-270004-01
Dated August 12, 2024
Rule 424(b)(8)
|
JPMorgan Chase Financial Company LLC |
|
|
|
|
Structured
Investments |
$1,480,000
Capped Notes Linked to the S&P 500®
Index due July 15, 2026
Fully and Unconditionally Guaranteed by JPMorgan Chase & Co. |
Notwithstanding anything to the contrary set forth in the pricing supplement
dated July 12, 2024 (CUSIP: 48135PJA0), related to the notes referred to above (the “pricing supplement”), the “Comparable
Yield and Projected Payment Schedule” is as follows:
COMPARABLE YIELD AND PROJECTED PAYMENT SCHEDULE —
We have determined that the “comparable yield” is an annual rate of 5.60%, compounded semiannually. Based on our determination
of the comparable yield, the “projected payment schedule” per $1,000 principal amount note consists of a single payment at
maturity, equal to $1,116.52. Assuming a semiannual accrual period, the following table sets out the amount of OID that will accrue with
respect to a note during each calendar period, based upon our determination of the comparable yield and projected payment schedule.
Calendar Period |
Accrued OID During
Calendar Period
(Per $1,000
Principal Amount
Note) |
Total Accrued OID from
Original Issue Date (Per
$1,000 Principal Amount
Note) as of End of Calendar
Period |
July 17, 2024 through December 31, 2024 |
$25.36 |
$25.36 |
January 1, 2025 through December 31, 2025 |
$58.22 |
$83.58 |
January 1, 2026 through July 15, 2026 |
$32.94 |
$116.52 |
Neither the comparable yield nor the projected payment schedule
constitutes a representation by us regarding the actual amount of the payment that we will make on the notes. The amount you actually
receive at maturity or earlier sale or exchange of your notes will affect your income for that year, as described in the pricing supplement
dated July 12, 2024 under “Treatment as Contingent Payment Debt Instruments.”
Investing in the notes involves a number of risks. See “Risk Factors”
beginning on page S-2 of the accompanying prospectus supplement, Annex A to the accompanying prospectus addendum, “Risk Factors”
beginning on page PS-12 of the accompanying product supplement and “Selected Risk Considerations” beginning on page PS-5 of
the pricing supplement.
Neither the Securities and Exchange Commission (the “SEC”) nor
any state securities commission has approved or disapproved of the notes or passed upon the accuracy or the adequacy of this pricing supplement
or the accompanying product supplement, underlying supplement, prospectus supplement, prospectus and prospectus addendum. Any representation
to the contrary is a criminal offense.
The notes are not bank deposits, are not insured by the Federal Deposit Insurance
Corporation or any other governmental agency and are not obligations of, or guaranteed by, a bank.
You should read this amendment together with the pricing supplement and the
related product supplement, prospectus supplement, prospectus and prospectus addendum, each of which can be accessed via the hyperlinks
below. Please also see “Additional Terms Specific to the Notes” in the pricing supplement.
| · | Pricing
supplement dated July 12, 2024: |
https://www.sec.gov/Archives/edgar/data/1665650/000121390024061626/ea177404_424b2.htm
![](https://www.sec.gov/Archives/edgar/data/1665650/000121390024067663/image_001.jpg)
JP Morgan Alerian MLP (AMEX:AMJ)
Historical Stock Chart
From Jul 2024 to Aug 2024
JP Morgan Alerian MLP (AMEX:AMJ)
Historical Stock Chart
From Aug 2023 to Aug 2024